Skip to main content
Premium Trial:

Request an Annual Quote

Gentris and Promega Will Jointly Develop Pharmacogenomic Products

NEW YORK, Sept. 9-Gentris, a North Carolina diagnostics company, will work with Promega to develop clinical pharmacogenomic products, the two companies said today.

 

The two companies will integrate their technologies into a robotic liquid handling platform designed to provide clinical guidance for physicians in drug prescription and dosing.

 

Promega, which specializes in biological reagents, will supply its Readit SNP-scoring system. Gentris, which offers pharmacogenomic tests for clinical trials and viral genotyping tests, is now working to develop genotyping kits for drug development.

 

The companies did not disclose financial details of the agreement.

 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.